|
| Phone Number |
+61 (0)7 3274 9009
+61 (0)7 3274 9001 (reception)
|
 |
|
Director
Professor Matti Lang
|
|
| Fascimile Number |
+61 (0)7 3274 9003 |
| Postal Address |
EnTox
39 Kessels Road
Coopers Plains QLD 4108
Australia
|
| Email |
m.lang@uq.edu.au |
|
Matti Lang took up his position as Professor and Director of the National Research Centre for Environmental Toxicology (EnTox) at the University of Queensland at the beginning of January 2009. He had previously held the title of Honorary Professor at the University of Queensland since 2005.
Past positions
- Professor and Chair of the Department of Pharmaceutical Biochemistry, Faculty of Pharmacy, University of Uppsala, (1997-2009).
- Head of Molecular Toxicology/ Mol. Carcinogenesis programme; WHO, International Agency for Research on Cancer in Lyon (1990-1997).
- Professor of Toxicology, University of Kuopio, Finland (1985-1990).
- Research Director, Eflab company, Helsinki, Finland, 1981-1985.
- Dean, Faculty of Pharmacy, University of Kuopio, (1988-1990).
- Visiting fellow / visiting scientist at the NIH /NIEHS in the US; at three occasions during 1979 –1988.
- PhD, University of Kuopio, Finland 1978.
|
|
Professor Lang's research focuses on the molecular mechanisms of a cell´s response to chemical and oxidative stress and mechanisms of chemical carcinogenesis. In particular, he is interested in the mechanisms of gene regulation, molecular genetics and individual drug sensitivity.
|
|
Dr A'edah Abu Bakar, Post Doctoral Research Fellow, is the main contact for Professor Lang's research team.
|
|
Professor Lang has trained about 25 PhD students in four different countries.
|
|
Professor Lang is a member of the University of Queensland Academic Board. He has been an invited speaker at a number of international meetings, referee for several peer reviewed journals and Chairman of the Finnish society of Toxicology
|
|
Professor Lang's publications include about 160 articles in high ranked peer reviewed journals, as well as chapters in books. In addition to these featured publications, a full list is available as a link from this page.
-
Raffalli-Mathieu, F., Glisovic, T., Ben David, Y. and Lang, M.A.,(2002), Heterogenous Nuclear Ribonucleoprotein A1 and Regulation of the Xenobiotic –Inducible Gene Cyp2A5, Molecular Pharmacology, 61, 795 – 799.
-
Hobro-Söderberg, M., Raffalli-Mathieu, F. and Lang, M.A, (2002), Inflammation modulates the interaction of heterogenous nuclear ribonucleoprotein (hnRNP) I/Polypyrimidine Tract Binding protein and hnRNP L with the 3`- Úntranslated region of the Murine Inducible Nitric-Oxide Synthase mRNA. Molecular Pharmacology, Vol 62, No 2, 423 431
-
Christian, K., Lang, M., Maurel, P. and Raffalli- Mathieu, F. (2004), Interaction of Heterogenous Nuclear Ribonucleoprotein A1 with Cytochrome P450 2A6 mRNA: Implications for Post-Transcriptional Regulation of the CYP2A6 gene, Molecular Pharmacology, 65, 1405-1414.
-
Söderberg, M., Raffalli-Mathieu, F. and Lang, M.A. (2007), Identification of a regulatory cis- element within the 3´-UTR of the murine inducible nitric oxide synthase (iNOS) mRNA; interaction with heterogenous nuclear ribonucleoproteins I and L and role in the iNOS gene expression. Mol. Immunol. 44, 434-442.
-
Christian, Kyle.J., Lang, M. A. and Raffalli-Mathieu, F (2008), Interaction of hnRNPC1/C2 with a novel cis- regulatory element within p53 mRNA as a response to cytostatic drug treatment. Mol Pharmacol. 73, 1-10.
|
|